International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Oncol Rep 37: [Related article:] 1451-1460, 2017; DOI: 10.3892/or.2017.5386
After the publication of the article, the authors informed us that they had consent from the patients involved in the study, but not from the next-of-kin of the patients, for their clinical data to have been published (Fig. 1A-E). Following on from a request made by the Ethics Committee of the Affiliated Hospital of Zunyi Medical College that these data either be replaced in the article, or that the article be retracted, the authors identified 10 new volunteers and asked the patients and their families to sign informed consent according to ethical requirements. The experiments were repeated according to the previous experimental design, and novel data were obtained. The results obtained were consistent with the previous clinical data. The revised version of Fig. 1, including the data from the new patients, is shown opposite. As stated, the revised data shown for Fig. 1A-E do not affect the overall conclusions reported in the paper. The authors apologize to the Editor of Oncology Reports and to the readership for any inconvenience caused.